Skip to main content

Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
tacrolimus
Description

The goal of this query was to identify kidney, heart, and liver transplant populations within the Sentinel Distributed Database (SDD) and evaluate their follow-up time. Among these populations, this query additionally investigated the continuous use of brand and generic oral tacrolimus following the transplant event.

The study period includes data from August 10, 2009 to October 31, 2017. We distributed this request to 17 Sentinel Data Partners on March 27, 2018.

Deliverables (1)
Sentinel Modular Program Report: Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
August 10, 2009 - October 31, 2017
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Assessing the Feasibility of Evaluating Tacrolimus Use after Solid Organ Transplantation in the Sentinel Distributed Database